Why the study?
Does transcatheter aortic valve implantation (TAVI) improve quality of life and all-cause mortality in elderly patients at 12 months?
Population
101 elderly patients undergoing transcatheter aortic valve implantation (TAVI)
Design
Cohort
Follow-up
12 months
Key result
Transcatheter aortic valve implantation in elderly patients was associated with incremental increases in quality of life VAS scores over 12 months (p<0.001) and a 12-month all-cause mortality of 17.8%.
Authors
Loading...
TAVI may support QoL consideration in elderly patients; leaves open randomized confirmation of benefits versus alternatives.
Cohort (n=101)
Does transcatheter aortic valve implantation (TAVI) improve quality of life and all-cause mortality in elderly patients at 12 months?
p-value: p=<0.001
TAVI significantly improves overall quality of life, specifically mobility and anxiety, in elderly patients at 12 months, with transfemoral access offering better early quality of life compared to non-transfemoral access.
Kleczyński et al. (2016) conducted a cohort in Elderly patients undergoing transcatheter aortic valve implantation (TAVI) (n=101). Transcatheter aortic valve implantation (TAVI) was evaluated on Changes in quality of life (VAS score) and all-cause mortality at 12 months (p=<0.001). Transcatheter aortic valve implantation in elderly patients was associated with incremental increases in quality of life VAS scores over 12 months (p<0.001) and a 12-month all-cause mortality of 17.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: